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October 20101112 AbstractsSummary: A number of individual case series have suggested blunt
traumatic thoracic aortic injury can be effectively managed with delayed
repair. The stimulus for delayed repair undoubtedly resulted from dissatis-
faction with the results of emergent operation, the greater availability of
endografts, and more widespread use of -blockers in the management of
thoracic aortic trauma. This study reports data from the American Associa-
tion for the Surgery of Trauma multicenter registry of 18 participating
trauma centers. It was observational and prospective, and data were acquired
from June 2005 through August 2007. Patients managed without aortic
repair or who were in extremis at presentation were excluded. Data collected
included clinical presentation, demographics, injury severity score, type of
aortic injury, type of aortic repair, and time from injury to aortic repair.
Patients were divided into groups according to early repair (24 hours) and
delayed repair (24 hours). Outcomes were compared with multivariate
analysis after adjustments for presence of hypertension, major associated
injuries, and type of aortic repair, as well as Glasgow Coma Scale. Patients
were also compared with delayed or early repair with respect to whether
there were underlying major associated injuries.
The study included 178 patients with thoracic aortic injuries, of whom
109 (61.2%) underwent early repair and 69 (38.8%) underwent delayed
repair. Demographics were similar in the two groups. Mortality was higher
in the early repair group (adjusted odds ratio, 7.8; 95% confidence interval
[CI], 1.69-35.70, P  .008). Complication rates were similar in the two
groups, but delayed repair was associated with longer lengths of stay in the
intensive care unit and in the hospital. Patients treated with early repair had
a trend toward a higher mortality rate (adjusted odds ratio, 9.1; 95% CI,
0.9-93.8, P .064). Early repair patients, however, had lower complication
rates (P  .04) and shorter intensive care unit stays (P  .02) than delayed
repair patients. There was a strong trend toward higher mortality in patients
with major associated injuries treated with early repair (odds ratio, 9.4; 95%
CI, 0.93-95.2; P  .058) without a difference in complication rates (P 
.239).
Comment: Delayed repair of blunt thoracic aortic injuries appears to
be safe but perhaps is associated with longer hospital lengths of stay and
higher direct costs than earlier repair. Overall, previous studies and the
current study suggest there is a survival advantage of delayed repair. Patients
with major associated injuries seem to benefit most with delayed repair, with
demonstrated improved survival and no increased systemic complications at
the expense of a longer length of stay than early repair. The data support
delayed repair in all patients with blunt thoracic aortic injuries irrespective of
risk factors. Patients with major associated injuries are most likely to benefit
from delayed repair.
Blunt Vertebral Artery Injuries in the Era of Computed Tomographic
Angiographic Screening: Incidence and Outcomes From 8292 Patients
Berne JD, Norwood SH. J Trauma 2009;67:1333-8.
Conclusion: An aggressive screening and individualized treatment
program for blunt vertebral artery injury can identify these injuries and
results in potentially a low rate of preventable strokes and deaths.
Summary:When patients are screened aggressively for blunt vertebral
artery injury (BVI) the incidence following appears to be 0.49% to 0.71%
(Miller PR, et al. Ann Surg 2002;236:386-95; and Berne JD, et al. J Trauma
2006;60:1204-10). This rate of identification of BVI appears to be higher
than in the prescreening era, where approximately 0.1% of patients with
blunt injuries were identified with BVI (Thibodeaux LC, et al. Br J Surg
1997;84:94). Stroke rates associate with BVI have been reported at 24%,
with BVImortality rates of 8% (BifflWL, et al. Ann Surg 2000;231:672-81).
The authors sought to determine whether screening and treatment for BVI
resulted in improved outcomes.
There were 8292 trauma patients admitted to the authors’ institution
between June 23, 2000, and December 31 2007. Of these, 47 had BVI (3
bilateral), and 37 patients were treated with pharmacologic therapy, heparin,
warfarin, or clopidogrel and aspirin. Treatment was with angiographic
coiling in eight patients (18%) and endovascular stents in two (5%). Four had
signs of cerebral ischemia, one of whom recovered completely and three
died. The mortality rate in the patients with BVI was 16%, and the BVI-
related mortality rate was 7%. Two patients with BVI-related mortality had
bilateral vertebral artery occlusion or transection. A posterior circulation
infarct developed in one patient after a unilateral vertebral dissection when it
was felt pharmacologic therapy was contraindicated secondary to intracranial
hemorrhage. Before the screening protocol in the authors’ institution,
BVI-related mortality was 0.75 cases/year, and during the study period it
was 0.57 cases/year.
Comment: The criteria for screening in the study included basilar skull
fractures, cervical spine injuries, severe facial fractures, and cervical hemato-
mas or cervical abrasions, as well as a Glasgow coma score 8 and lateraliz-
ing neurologic signs and mechanism of hanging for the injury. All patients
had sustained a high-speed deceleration incident or blunt cervical trauma,
and 86.4% of the BVI patients were identified by screening criteria alone.
Patients overall did well, with only one possibly preventable death from BVI.
What this study tells us is that patients with BVI identified through screeningand treated with a variety of modalities will have low neurologic morbidity
and mortality.
Changes in Red Blood Cell Transfusion Practice During the Turn of
the Millennium: A Retrospective Analysis of Adult Patients Undergo-
ing Elective Open Abdominal Aortic Aneurysm Repair Using theMayo
Database
Long TR, Curry TB, Stemmann JL, et al. Ann Vasc Surg 2010;24:447-54.
Conclusion:Change in transfusion practice, including the use of more
autotransfusions and tolerance of lower perioperative hemoglobin levels,
have not resulted in significant differences in perioperative morbidity or
mortality in patients undergoing open abdominal aortic aneurysm (AAA)
repair.
Summary: The average cost of the transfusion of a red blood cell
(RBC) unit is $153.68, and 14million units of RBCs are transfused annually
in the United States (Sullivan NT, et al. Transfusion 2007;47:385-94).
Currently, there is also enthusiasm for reducing the number of transfused
units because of reported increased morbidity and mortality with increased
transfusions and reported increased infectious complications with increased
transfusions. The authors sought to determine whether changes in transfu-
sion practice during a two-decade study had any impact on perioperative
morbidity and mortality in patients undergoing open elective AAA repair.
The authors stratified patients undergoing open elective AAA repair into one
of two transfusion-related groups. Early practice was defined as that between
1980 and 1982, and late practice was defined as between 2003 and 2006.
Hemoglobin concentration and RBC transfusion were analyzed as contin-
uous variables and compared between groups. Perioperative complications
were compared, and data were age adjusted and analyses corrected for
multiple comparisons.
Patients in the late practice group compared with those in the early
practice group had lower intraoperative (mean, 10  1.4 vs 11.5  1.5
g/dL), postoperative (mean, 11.9 1.4 vs 13.4 1.5 g/dL), and discharge
hemoglobin levels (mean, 10.8  1.2 vs. 12.5  1.5 g/dL; P  .0001 for
each variable). Fewer patients in the late practice group received intraoper-
ative allogenic transfusions (46% vs 99%, P .0001). There were also fewer
total allogenic units transfused in the late practice group (mean, 1.7 vs 4.3,
P  .0001). No patients in the early practice group had intraoperative
autotransfusions, whereas intraoperative autotransfusions were used in 97%
of the late practice patients (P  .0001). The incidence of perioperative
morbidity and mortality was 40% (n  119) in the late practice group and
35% (n  106) in the early practice group (P  .27).
Comment: RBC transfusion is associated with worse outcomes in
cardiac surgery patients and in patients experiencing acute coronary syn-
drome (Murphy GJ, et al. Circulation 2007;116:2544-52; and Rao SV.
JAMA 2004;292:1555-62). However, a randomized trial in critically ill
patients comparing liberal vs conservative RBC transfusion found no differ-
ence in survival with the two treatment strategies (Hebert PC, et al. N Engl
J Med 1999;340:409-47). The current study also found no difference in
major morbidity or mortality in patients undergoing AAA repair with respect
to a changing transfusion policy using more conservative thresholds for
transfusion. However, the patients did no worse, and given the expense
occurred with each unit transfused, a more conservative policy for patients
undergoing open AAA repair is at least indicated financially if not medically.
Damage Control Techniques for Common and External Iliac Artery
Injuries: Have Temporary Intravascular Shunts Replaced the Need for
Ligation?
Ball CG, Feliciano DV. J Trauma 2010;68:1117-20.
Conclusion: Temporary intravascular shunts (TIVSs) have replaced
ligation as primary damage control for injuries to the common and external
iliac artery. TIVs substantially eliminate the need for amputation in patients
with these injuries and provide improved likelihood of survival.
Summary: Iliac artery trauma is highly lethal, with mortality rates
ranging from 24% to 60% (Dente CJ, Feliciano DV. In: Feliciano DV,
Mattox KL, Moore EE, editors. Trauma. 6th ed. New York: McGraw-Hill
Medical; 2008. p. 737-57). Traditional damage control for iliac artery
injuries has been ligation and was associated with a 50% amputation rate and
up to a 90% mortality rate. The goal of this study was to identify the
consequences of using ligation vs TIVS for common or external iliac artery
injuries in damage control scenarios. From 1995 to 2008, patients with iliac
artery injuries were identified at a level 1 trauma center and were analyzed for
demographics and outcomes. There were 88 patients with iliac artery
injuries, comprising 71 external and 17 common iliac artery injuries; of
these, 72% were penetrating, and the median injury severity score (ISS) was
25. The mean hospital stay was 28 days. Nonsurvivors (73%) died of
refectory shock within the first 24 hours. Ligation was used in 1 common
(6%) and in 14 external (20%) iliac arteries, and TVISs were used in 2
common (12%) and in 5 external (7%) iliac arteries. Ligation was practiced
primarily between 1995 and 2005 and TIVs between 2005 and 2008.
Patients undergoing ligation or TIVS had similar demographics and injuries.
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had fewer amputations (47% vs 0%) and fewer fasciotomy procedures (93% vs
43%; P  .05). Mortality was 72% in the ligation group vs 43% in the TIVS
group. In the patients treated with a TIVS, no TIVS thrombosed, and the
mean shunt time was 22.3 hours.
Comment: Temporary intravascular shunts have long been used as a
method of temporarily restoring arterial circulation in patients with periph-
eral arterial injuries distal to the axillary crease and inguinal ligament.
Prolonged use for maintaining arterial circulation after injuries at other sites
is less recognized. The article indicates that a major vascular injury within the
abdomen does not necessarily need to be acutely repaired in damage control
situations. A shunt can be placed, the patient resuscitated, and the coagu-
lopathy corrected, or the patient brought back to the operating room for
interval repair of vascular and associated injuries. This may result in fewer
amputations and improved survival.
Isolated Gastrocnemius and Soleal Vein Thrombosis: Should These
Patients Receive Therapeutic Anticoagulation?
Lautz TB, Abbas F, Novis SJ, et al. Ann Surg 2009;251:735-42.
Conclusion: Isolated gastrosoleal venous thrombosis (IGSVT) is asso-
ciated with a significant rate of venous thromboembolism (VTE), and this
rate of VTE can be reduced with therapeutic anticoagulation.
Summary:Only a few studies have focused on optimal management of
isolated IGSVT. The incidence and prevalence of IGSVT appears to be
significant, accounting for 15% to 25% of patients with lower extremity
thrombus on venous duplex examinations (J Vasc Surg 1999;30;787-91).
However, very few studies have quantified the natural history of IGSVT and
the effects of anticoagulation or no anticoagulation on IGSVT propagation
or resolution. The authors reviewed 34,426 lower extremity venous duplex
studies from their vascular laboratory during April 2002 to April 2007 andfound 784 patients with IGSVT in one or more limbs. Of these, 38 had
concurrent contralateral DVT, and 296 lacked follow-up data and were
excluded from analysis. Forty-four patients had a simultaneous confirmed
diagnosis of PE and were analyzed separately because they might have had a
deep venous thrombosis (DVT) that embolized. The remaining 406 patients
with IGSVT in 452 limbs were included in the primary analysis. Mean
follow-up of these patients was 7.5 11 months. The left limb was affected
in 47.3%, the right limb in 41.4%, and both limbs in 11.3%. Gastrocnemius
veins were involved in 60.1%, soleal veins alone in 36.5%, and both gastroc-
nemius and soleal veins in 3.4%. VTE events, defined as axial DVT or
pulmonary embolism, occurred in 76 patients (18.7%) after the diagnosis of
IGSVT. Of that 18.7%, 3.9% was pulmonary embolism, 16.3% was DVT,
and 1.5% was both PE andDVT. Incidence of VTEwas 30% (36 of 119) and
27% (13 of 48) in patients who received no or prophylactic anticoagulation,
respectively. Incidence of VTE was 12% (23 of 188) in patients treated with
therapeutic anticoagulation (P  .0003). Lack of therapeutic anticoagula-
tion (P  .017) and a history of VTE (P  .011) were independent
predictors of subsequent VTE development in patients with initial IGSVT.
IGSVT resolution during follow-up was 61.2% in patients treated with
therapeutic anticoagulation but only 40% and 41% in patients treated with
prophylactic or no anticoagulation, respectively (P  .003).
Comment:Accumulating data suggest IGSVTmay not be benign, and
its natural history may be favorably influenced by anticoagulation. However,
there is no randomized study of the efficacy of anticoagulation in patients
with IGSVT. In retrospective studies such as this, it may be that high-risk
patients for treatment with anticoagulation may have therapy withheld, and
those same risk factors contributed to the apparent adverse natural history of
IGSVT.With increasing numbers of IGSVT being recognized, a multicenter
randomized trial of the efficacy of anticoagulation in patients with IGSVT is
required to guide therapy for this increasingly commonly recognized con-
dition.
